LifeMD vs MEDVi
MEDVi has an open FDA warning letter dated February 20, 2026. LifeMD has none. No price lines up like for like: LifeMD and MEDVi publish prices for different products.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
LifeMD / MEDVi
LifeMD
6.0/10
MEDVi
7.7/10
Neither LifeMD nor MEDVi pays us. Links to them earn nothing. Scores: LifeMD 6.0, MEDVi 7.7. How we are paid
What the record shows
- 01
MEDVi has an open FDA warning letter dated February 20, 2026. LifeMD has none.
- 02
MEDVi names three pharmacies, all 503A. LifeMD sells brand-name medication only.
- 03
No price lines up like for like: LifeMD and MEDVi publish prices for different products.
- 04
Only LifeMD lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill. Only MEDVi lists a price for compounded semaglutide injection.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
LifeMD
MEDVi
$199/mo
$2,388 a year
$348/mo
$4,176 a year
$448/mo
$5,376 a year
$298/mo
$3,576 a year
Read off each seller’s own pages. LifeMD: October 31, 2026. MEDVi: October 25, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for LifeMD
6.0/10- No FDA warning letter on record
- Sells brand-name semaglutide pen and brand-name tirzepatide pen, which MEDVi does not price
- Price leaves out medication
The case for MEDVi
7.7/10- Sells compounded semaglutide injection, which LifeMD does not price
- Open FDA warning letter, February 20, 2026
Scores
LifeMD 6.0 · MEDVi 7.7 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
LifeMD vs MEDVi: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Eden8.7
From $99/mo
Visit site - MyDrHank6.4
From $171/mo prepaid
Visit site - Luvo Health7.9
From $179/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks